![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CD69 |
Gene summary for CD69 |
![]() |
Gene information | Species | Human | Gene symbol | CD69 | Gene ID | 969 |
Gene name | CD69 molecule | |
Gene Alias | AIM | |
Cytomap | 12p13.31 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q07108 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
969 | CD69 | CA_HPV_1 | Human | Cervix | CC | 1.25e-05 | -1.63e-01 | 0.0264 |
969 | CD69 | CA_HPV_3 | Human | Cervix | CC | 1.24e-02 | -2.48e-01 | 0.0414 |
969 | CD69 | HSIL_HPV_1 | Human | Cervix | HSIL_HPV | 1.00e-07 | -5.91e-01 | 0.0116 |
969 | CD69 | HSIL_HPV_2 | Human | Cervix | HSIL_HPV | 1.14e-20 | -7.61e-01 | 0.0208 |
969 | CD69 | N_HPV_2 | Human | Cervix | N_HPV | 3.55e-19 | -5.06e-02 | -0.0131 |
969 | CD69 | CCI_1 | Human | Cervix | CC | 1.23e-03 | -8.09e-01 | 0.528 |
969 | CD69 | CCI_2 | Human | Cervix | CC | 3.50e-03 | -8.09e-01 | 0.5249 |
969 | CD69 | CCI_3 | Human | Cervix | CC | 5.04e-04 | -7.94e-01 | 0.516 |
969 | CD69 | CCII_1 | Human | Cervix | CC | 2.82e-08 | -8.09e-01 | 0.3249 |
969 | CD69 | Tumor | Human | Cervix | CC | 1.05e-26 | -8.09e-01 | 0.1241 |
969 | CD69 | sample1 | Human | Cervix | CC | 1.27e-06 | -8.09e-01 | 0.0959 |
969 | CD69 | sample3 | Human | Cervix | CC | 2.10e-22 | -8.00e-01 | 0.1387 |
969 | CD69 | H2 | Human | Cervix | HSIL_HPV | 2.34e-19 | -7.40e-01 | 0.0632 |
969 | CD69 | T1 | Human | Cervix | CC | 8.70e-14 | -7.97e-01 | 0.0918 |
969 | CD69 | T3 | Human | Cervix | CC | 1.78e-23 | -8.03e-01 | 0.1389 |
969 | CD69 | LZE11D | Human | Esophagus | HGIN | 1.69e-02 | 3.75e-01 | -0.005 |
969 | CD69 | LZE4T | Human | Esophagus | ESCC | 9.16e-11 | 1.30e+00 | 0.0811 |
969 | CD69 | LZE7T | Human | Esophagus | ESCC | 5.83e-04 | 6.33e-01 | 0.0667 |
969 | CD69 | LZE6T | Human | Esophagus | ESCC | 3.66e-23 | 2.88e+00 | 0.0845 |
969 | CD69 | P16T-E | Human | Esophagus | ESCC | 4.29e-03 | 2.57e-01 | 0.1153 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Breast | ADJ |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Breast | DCIS |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Breast | Healthy |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Breast | IDC |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Breast | Precancer |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Cervix | ADJ |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Cervix | CC |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Cervix | Healthy |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Cervix | Precancer |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | CRC | MSI-H |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Endometrium | ADJ |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Endometrium | AEH |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Endometrium | EEC |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Endometrium | Healthy |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | Esophagus | ADJ |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | GC | ADJ |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | GC | GC |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | GC | Healthy |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | GC | Precancer |
CD69 | KLRB1 | CLEC2C_KLRB1 | CLEC | HNSCC | ADJ |
Page: 1 2 3 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CD69 | SNV | Missense_Mutation | novel | c.574T>C | p.Trp192Arg | p.W192R | Q07108 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
CD69 | SNV | Missense_Mutation | novel | c.358N>A | p.Leu120Ile | p.L120I | Q07108 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
CD69 | SNV | Missense_Mutation | novel | c.119N>A | p.Pro40His | p.P40H | Q07108 | protein_coding | deleterious(0) | probably_damaging(0.968) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CD69 | SNV | Missense_Mutation | novel | c.16N>G | p.Cys6Gly | p.C6G | Q07108 | protein_coding | tolerated_low_confidence(0.19) | benign(0) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CD69 | SNV | Missense_Mutation | rs746297540 | c.260N>G | p.Glu87Gly | p.E87G | Q07108 | protein_coding | tolerated(0.07) | benign(0) | TCGA-CC-A7IH-01 | Liver | liver hepatocellular carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
CD69 | SNV | Missense_Mutation | c.533A>C | p.Asn178Thr | p.N178T | Q07108 | protein_coding | tolerated(0.28) | benign(0.013) | TCGA-RG-A7D4-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CD69 | SNV | Missense_Mutation | c.332N>T | p.Asn111Ile | p.N111I | Q07108 | protein_coding | deleterious(0.03) | benign(0.085) | TCGA-55-7911-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
CD69 | SNV | Missense_Mutation | novel | c.124C>A | p.Leu42Met | p.L42M | Q07108 | protein_coding | deleterious(0.03) | benign(0.187) | TCGA-77-A5G3-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CD69 | SNV | Missense_Mutation | novel | c.549C>A | p.Ser183Arg | p.S183R | Q07108 | protein_coding | deleterious(0.02) | benign(0.197) | TCGA-85-8666-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
CD69 | SNV | Missense_Mutation | novel | c.548G>C | p.Ser183Thr | p.S183T | Q07108 | protein_coding | tolerated(0.1) | benign(0.034) | TCGA-85-8666-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
969 | CD69 | EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | ANTITUMOR ANTIBIOTICS | 11811939 | ||
969 | CD69 | EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | tocilizumab | TOCILIZUMAB | 27339827 |
Page: 1 |